Scientists test 'Recharged' blood stem cells to fight bone marrow disorder
NCT ID NCT06465160
Summary
This early-stage study is testing the safety of a new cell therapy called MNV-201 for adults with low-risk myelodysplastic syndrome (MDS), a bone marrow disorder that causes low blood counts. The therapy involves taking a patient's own blood stem cells, boosting them with mitochondria (the energy centers of cells) from donated placenta tissue, and infusing them back. The main goal is to see if this approach is safe and if it can help improve anemia and reduce the need for blood transfusions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shaare Zedek Medical Center
RECRUITINGJerusalem, Israel, 9103102, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.